Dr. Martin D’Amours has been practicing endocrinology at the CHU of Quebec since 2009. He is a Clinical Professor at Laval University and the head of the endocrine system course for medical students.
He completed a pre-doctoral medical training (PhD) in experimental medicine on endothelial dysfunction in chronic renal failure at l’Hôtel-Dieu de Québec. He subsequently completed his medical training at Laval University, followed by a sub-specialization in endocrinology at the Université de Montréal.
Dr. D’Amours is a Clinical Research Associate at the CHUL Research Centre where he is involved in several clinical studies within the diabetes research unit. His main interests are the endocrinology of pregnancy, the pathophysiology of cardiovascular risk factors, endothelial dysfunction and new therapeutic approaches to diabetes.
2705, boulevard Laurier
Canada G1V 4G2
Data not available
Beyond glycaemic control: A cross-over, double-blinded, 24-week intervention with liraglutide in type 1 diabetes.Journal Article
Diabetes Obes Metab, 20 (1), pp. 178-184, 2018, ISSN: 1462-8902.
Increased ET-1 and reduced ET(B) receptor expression in uremic hypertensive rats.Journal Article
Clin Exp Hypertens, 32 (1), pp. 61-9, 2010, ISSN: 1064-1963.
Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats.Journal Article
J Hypertens, 19 (8), pp. 1479-87, 2001, ISSN: 0263-6352.
Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats.Journal Article
Nephrol Dial Transplant, 16 (4), pp. 746-54, 2001, ISSN: 0931-0509.
Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.Journal Article
Can J Physiol Pharmacol, 77 (1), pp. 8-16, 1999, ISSN: 0008-4212.
- Centre hospitalier universitaire de Québec - CHU de Québec-Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31